Mr. Speaker, the third petition is from the United Senior Citizens of Ontario Inc.
They draw to the attention of the House and call on Parliament to request the longstanding Canadian practice of marketing generic drugs in a size, shape and colour which is similar to that of its brand name equivalent. They are concerned about the safety of consumers.